Literature DB >> 9204909

Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area.

M J Nirenberg1, J Chan, R A Vaughan, G R Uhl, M J Kuhar, V M Pickel.   

Abstract

The dopamine transporter (DAT) plays an important role in the plasmalemmal reuptake of dopamine and, thus, in the termination of normal dopaminergic neurotransmission. DAT is also a major binding site for cocaine and other stimulants, the psychoactive effects of which are associated primarily with the inhibition of dopamine reuptake within mesocorticolimbic dopaminergic neurons. We used electron microscopy with an anti-peptide antiserum directed against the N-terminal domain of DAT to determine the subcellular localization of this transporter in the rat ventral tegmental area (VTA), the region that contains the cell bodies and dendrites of these dopaminergic neurons. We show that in the VTA, almost 95% of the DAT immunogold-labeled profiles are neuronal perikarya and dendrites, and the remainder are unmyelinated axons. Within perikarya and large proximal dendrites, almost all of the DAT immunogold particles are associated with intracellular membranes, including saccules of Golgi and cytoplasmic tubulovesicles. In contrast, within medium- to small-diameter dendrites and unmyelinated axons, most of the DAT gold particles are located on plasma membranes. In dually labeled tissue, peroxidase reaction product for the catecholamine-synthesizing enzyme tyrosine hydroxylase is present in DAT-immunoreactive profiles. These findings suggest that intermediate and distal dendrites are both the primary sites of dopamine reuptake and the principal targets of cocaine and related psychostimulants within dopaminergic neurons in the VTA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9204909      PMCID: PMC6793826     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  58 in total

1.  Ultrastructural localization of tyrosine hydroxylase in the rat ventral tegmental area: relationship between immunolabeling density and neuronal associations.

Authors:  V E Bayer; V M Pickel
Journal:  J Neurosci       Date:  1990-09       Impact factor: 6.167

Review 2.  Telencephalic projections of the A8 dopamine cell group.

Authors:  A Y Deutch; M Goldstein; F Baldino; R H Roth
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  Quantitative autoradiographic localization of the dopamine transport complex in the rat brain: use of a highly selective radioligand: [3H]GBR 12935.

Authors:  T M Dawson; D R Gehlert; J K Wamsley
Journal:  Eur J Pharmacol       Date:  1986-07-15       Impact factor: 4.432

4.  Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse.

Authors:  G L Bernardini; X Gu; E Viscardi; D C German
Journal:  J Neural Transm Gen Sect       Date:  1991

5.  Behavioral and pharmacological modulation of ventral tegmental dendritic dopamine release.

Authors:  H Zhang; E A Kiyatkin; E A Stein
Journal:  Brain Res       Date:  1994-09-05       Impact factor: 3.252

6.  Monoaminergic synapses, including dendro-dendritic synapses in the rat substantia nigra.

Authors:  C J Wilson; P M Groves; E Fifková
Journal:  Exp Brain Res       Date:  1977-11-24       Impact factor: 1.972

7.  Dopaminergic modulation of dye coupling between neurons in the core and shell regions of the nucleus accumbens.

Authors:  P O'Donnell; A A Grace
Journal:  J Neurosci       Date:  1993-08       Impact factor: 6.167

8.  Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.

Authors:  S N Haber; H Ryoo; C Cox; W Lu
Journal:  J Comp Neurol       Date:  1995-11-20       Impact factor: 3.215

9.  Mesolimbic dopaminergic neurones and somatodendritic mechanisms.

Authors:  P M Beart; D McDonald; A L Gundlach
Journal:  Neurosci Lett       Date:  1979-12       Impact factor: 3.046

10.  Axonal and dendritic endocytic pathways in cultured neurons.

Authors:  R G Parton; K Simons; C G Dotti
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

View more
  31 in total

1.  The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens.

Authors:  M J Nirenberg; J Chan; A Pohorille; R A Vaughan; G R Uhl; M J Kuhar; V M Pickel
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  Designing human m1 muscarinic receptor-targeted hydrophobic eigenmode matched peptides as functional modulators.

Authors:  Karen A Selz; Arnold J Mandell; Michael F Shlesinger; Vani Arcuragi; Michael J Owens
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

3.  Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.

Authors:  Erica Bowton; Christine Saunders; Kevin Erreger; Dhananjay Sakrikar; Heinrich J Matthies; Namita Sen; Tammy Jessen; Roger J Colbran; Marc G Caron; Jonathan A Javitch; Randy D Blakely; Aurelio Galli
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

4.  Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents.

Authors:  Christopher P Ford; Michael J Beckstead; John T Williams
Journal:  J Neurophysiol       Date:  2006-11-22       Impact factor: 2.714

Review 5.  Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission.

Authors:  R Exley; S J Cragg
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

6.  Dopamine D₂ and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area.

Authors:  M Garzón; A M Duffy; J Chan; M-K Lynch; K Mackie; V M Pickel
Journal:  Neuroscience       Date:  2013-08-15       Impact factor: 3.590

Review 7.  Somatodendritic dopamine release: recent mechanistic insights.

Authors:  Margaret E Rice; Jyoti C Patel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

Review 8.  Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment.

Authors:  E S Vizi; A Fekete; R Karoly; A Mike
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

9.  Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs.

Authors:  O Cases; C Lebrand; B Giros; T Vitalis; E De Maeyer; M G Caron; D J Price; P Gaspar; I Seif
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

10.  Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter.

Authors:  Manuel Miranda; Kalen R Dionne; Tatiana Sorkina; Alexander Sorkin
Journal:  Mol Biol Cell       Date:  2006-11-01       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.